New In Vivo Syngeneic Mammary Fat Pad Mouse Model Shuttle Session - by Explicyte Immuno-Oncology
OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer | npj Breast Cancer
New shuttle session with our in vivo syngeneic tumor models – for cost-saving efficacy studies - by Explicyte Immuno-Oncology
CC inhibits in vivo tumor growth and lung metastasis in 4T1-syngeneic... | Download Scientific Diagram
Marizomib suppresses triple-negative breast cancer via proteasome and oxidative phosphorylation inhibition
Model 4T1 | CrownBio
MIND model for triple-negative breast cancer in syngeneic mice for quick and sequential progression analysis of lung metastasis | PLOS ONE
In-vivo antitumor activity of compound 19 in a syngeneic (4T1 induced)... | Download Scientific Diagram
Syngeneic breast-cancer metastasis model. 4T1 cells were introduced to... | Download Scientific Diagram
4T1 Syngeneic Murine Model - Altogen Labs
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response - ScienceDirect
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
4T1-luc2-1A4 tumor metastases in syngeneic Balb/c mice. (A) Metastases... | Download Scientific Diagram
Frontiers | Comparative Profiling of Metastatic 4T1- vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer
Local angiotensin II contributes to tumor resistance to checkpoint immunotherapy | Journal for ImmunoTherapy of Cancer
JCI Insight - Metastasis regulation by PPARD expression in cancer cells
In vivo orthotopic breast tumor model - by Explicyte Immuno-Oncology
Primary tumor-induced immunity eradicates disseminated tumor cells in syngeneic mouse model | Nature Communications
Induction of oligoclonal CD8 T cell responses against pulmonary metastatic cancer by a phospholipid-conjugated TLR7 agonist | PNAS
Epithelial-type systemic breast carcinoma cells with a restricted mesenchymal transition are a major source of metastasis | Science Advances
Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis | Anticancer Research
Establishment of a murine breast tumor model by subcutaneous or orthotopic implantation
Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment
Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation: Molecular Therapy
